A Phase Ib, Dose Finding Study Evaluating AZD1775 in Monotherapy, in Combination With Carboplatin and Paclitaxel, and in Combination With Only Carboplatin in Adult Asian Patients With Advanced Solid Tumours
Phase of Trial: Phase I
Latest Information Update: 15 Nov 2017
At a glance
- Drugs AZD-1775 (Primary) ; Carboplatin; Paclitaxel
- Indications Solid tumours
- Focus Adverse reactions
- Sponsors AstraZeneca
- 09 Nov 2017 Status changed from active, no longer recruiting to completed.
- 30 Oct 2017 Results assessing safety presented at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics 2017.
- 08 Sep 2017 Planned End Date changed from 27 Jun 2018 to 29 Sep 2017.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History